United Kingdom Europe
in Europe
Discover our cosmetic ingredient manufacturing capabilities, fine chemicals and custom synthesis of pharma intermediates capabilities
About the plant
Manchester
Development and manufacturing and non-GMP
Our facility in Manchester is fully integrated into the in-house supply chain for complex APIs.
Activities
- Process research and custom synthesis of pharmaceutical intermediates, cosmetic ingredients and fine chemicals
- Larger production capacity (up to 4,500 L)
- Production of early-phase APIs and large-scale intermediates
Certifications
Activity
- manufacturing
Features
- Uses:
- Toxicity (OEB classification):
- DEA: N/A
- BSL:
- Therapeutic areas: N/A
- Markets:
Batch Size / Reactor
Services
Get in touch
in Europe
Custom development and automated aseptic production of liquid and lyophilized drug productCHEMICAL-SYNTHETIC BIOLOGICS SERVICES in Europe
Development and cGMPmanufacturing of Highly Potent API including Antibody Drug Conjugates (ADC) in Europe
Large scale manufacturing of Cholesterol and Vitamin D analogs
Other plants of this company
in Europe Custom development and automated aseptic production of liquid and lyophilized drug product
CHEMICAL-SYNTHETIC BIOLOGICS SERVICES in Europe Development and cGMPmanufacturing of Highly Potent API including Antibody Drug Conjugates (ADC)
in Europe Large scale manufacturing of Cholesterol and Vitamin D analogs
